-
NT-proBNP (1-76) ELISACatalog #: 04-SK-1204
Sensitivity: 3 pmol/l
Range: 0-640 pmol/l
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Prostacyclin ELISA (Urine)
Catalog #: 74-PCNHU-E01-URN
Sensitivity: 6.58 pg/mL
Range: 7.81 - 2,000 pg/mL
Sample Types: Cell Culture, Urine
Sample Size(s): 96 Wells
Detection: Colorimetric -
Prostacyclin ELISA (Urine) 5 Plate
Catalog #: 74-PCNHU-E05-URN
Sensitivity: 6.58 pg/mL
Range: 7.81 - 2,000 pg/mL
Sample Types: Cell Culture, Urine
Sample Size(s): 5 x 96 Wells
Detection: Colorimetric -
EasySampler® Stool Collection KitCatalog #: 58-EZSAMPLER
Sample Types: Stool
-
Acylated Ghrelin (human) Easy Sampling ELISA
Catalog #: 32-5306
-
NGAL Sample Collection Kit
Catalog #: 43-NGALEX-50
Sample Types: Stool
-
NGAL (Lipocalin-2) ELISA
Catalog #: 43-NGALHU-E01
Sensitivity: 0.14 ug/g stool; 0.04 ng/mL urine
Range: 1 - 97 ug/g stool; 0.3 - 27 ng/mL urine
Sample Types: Stool, Urine
Sample Size(s): 96 Wells
-
Human Synthetic 25-OH Vitamin D3 LC Biotin 100 ng
Catalog #: 30-A1025AG.5
Sample Size(s): Other
-
Human Synthetic 25-OH Vitamin D3 LC Biotin 1 µg
Catalog #: 30-A1025AG.6
Sample Size(s): Other
-
Calcitonin Gene Related Peptide ELISA (CGRP ELISA)
Catalog #: 32-5481
Sensitivity: 5 pg/mL
Range: 7.81 - 1000 pg/mL
Sample Types: Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
GeneProof Parvovirus B19 PCR KitCatalog #: 60-B19-002-100
Sample Types: Plasma, Whole Blood
Sample Size(s): 100 Tests
-
AcSDKP ELISA (N-acetyl-Ser-Asp-Lys-Pro)
Catalog #: 32-5881
Sensitivity: 0.19 nM
Range: 0.19 - 25 nM
Sample Types: Plasma, Serum, Urine
Sample Size(s): 96 Wells
Detection: Colorimetric
Alpco Home Page
New: Calprotectin Immunoturbidimetric Assay will take your testing to the next level. Learn more.Supporting your work with life science and clinical testing productsVIEW ALL LIFE SCIENCE PRODUCTSVIEW ALL CLINICAL DIAGNOSTIC PRODUCTS
Tips & Tricks
The Enzyme-Linked Immunosorbent Assay (ELISA) is a proven sensitive method for detecting and quantifying specific biomarkers in a wide range of clinical and research samples. The accuracy and precision of ELISAs can be affected by many factors, including pipetting, washing, and sample-handling techn...
Company Overview
Accuracy and Efficiency. Together.We are a leading global developer and provider of innovative molecular and immunodiagnostic products focused on Infectious and Gastroenterological Diseases. We are a trusted partner creating value for research and clinical laboratories with high-quality, user-frien...
Responsibility
ALPCO’s Diabetes Research Travel GrantALPCO strives to provide scientists and healthcare professionals with robust tools for their research and clinical diagnostic endeavors. We understand that championing extraordinary discoveries requires extraordinary efforts, and support. We are proud to continu...
Differentiating Gastrointestinal Pathogens from IBD and IBS
Gastrointestinal (GI) disorders such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), as well as infections from GI pathogens can present very similar symptoms. A host of tests have been developed to aid in the differentiation between IBD and IBS, such as calprotectin and lact...
Complement System Solutions for Drug Development and Clinical Research
Datasheet: Complement System Immunoassays
Download
The complement system is essential to innate immunity which protects from chronic, autoimmune, and infectious disease. There are three distinct pathways of complement activation: classical, lectin/MBL, and alternative. Each leads...
Heart Disease Biomarkers in Diabetes Research
Introduction
Cardiovascular disease (CVD) encompasses a constellation of diseases related to the heart and circulatory system. Despite efforts to understand and combat CVD complications from diabetes, 65% of diabetics will pass away from cardiovascular issues1. Part 2 of The Common Denominator eBoo...
Physiological Actions of Natriuretic Peptides
Introduction
Humans have at least 50 discovered hormones managing vital biological functions in the body. These hormones are produced by the body’s organs and glands. Natriuretic peptides (NPs) are structurally related hormones synthesized and released from the heart, including atrial natriuretic p...
Early Detection of Diabetic Kidney Disease with Biomarkers
Introduction
Over one third of diabetics will develop diabetic kidney disease (DKD) in their lifetime1. Despite the large amount of diabetics suffering from DKD, current methods for measuring and tracking kidney function may not be specific enough for diabetic systems2,3.
Part III of The Common ...
De-escalating Inflammatory Bowel Disease Therapies
Date: June 21, 2016
Author: Andrea Tarbet, Product Marketing Associate at ALPCO
Several therapies exist to help treat inflammatory bowel disease (IBD) and improve patient quality of life. However, a growing number of gastroenterologists and patients have been choosing to stop these therapies -...
Regulating Endocrine Disrupting Chemicals in Consumer Products
Date: September 27, 2016
Author: Andrea Tarbet, Product Marketing Associate at ALPCO
From cosmetics to water bottles, endocrine disrupting chemicals (EDCs) have surfaced in our everyday lives. EDCs are compounds that can interfere with the endocrine system’s ability to help an organism develop...
Endocrine Disrupting Chemicals and Biomarkers
Introduction
Humans and the environment are exposed to numerous chemicals every day1. Each year, about 2,000 new chemicals are manufactured in the U.S.2. Research findings over the years have shown how some chemicals known as endocrine disrupting chemicals (EDCs) can interact with the endocrine sys...
Choosing the Relevant GLP-1 Species to Study
A better understanding of incretins has led to tremendous therapeutic advances in the field of type 2 diabetes1. These hormones are released from the gut in response to food ingestion and lead to the stimulation of pancreatic β-cells which then release insulin in a glucose-concentration de...
Adipokines and Adipose Tissue-Liver Crosstalk in Energy Metabolism
Research over the past several decades examining adipokines and adipose tissue-liver crosstalk in energy metabolism has revealed that adipose tissue is a very important metabolically active endocrine organ1. White, brown, and beige adipose tissue generate and secrete adipokines, such as adiponectin ...
Researching the Role of Gut Permeability in NAFLD
[playlist images="false" artists="false" tracklist="false" ids="4600"]
A growing amount of research demonstrates that communication between the gut microbiota and liver is vital for the regulation of energy metabolism1,2. As a result, scientists are further...
Researching Therapeutic Drug Monitoring for IBD
Multiple classes of biologics are available for the treatment of inflammation associated with inflammatory bowel disease (IBD) which ultimately improves the quality of life for patients. However, many challenges are associated with using biologics to treat IBD such as immunogenetic reactions and th...
Challenges When Treating IBD with Biologics
Monoclonal antibody (mAbs) biologics have been used to treat inflammatory bowel disease (IBD) for 20 years1. Despite the successful use of biologics as therapies for Crohn’s disease (CD) and ulcerative colitis (UC), these diseases remain difficult to manage. As a result, patients and healthcare prov...
IBS Awareness Month: Facts About IBS
In support of IBS Awareness Month, we created this short video to share some important facts about IBS and spread the word about this incurable, debilitating disorder.
Be sure to like and share our video to show your support of IBS Awareness Month!
https://youtu.be/6K_55Bg922s
Quick Facts Abo...
ALPCO Announces its January 2019 Diabetes Research Travel Grant Recipient
February 5, 2019
ALPCO announced the latest recipient of its Young Investigator Award, the Diabetes Travel Grant. The grant was created to help advance progressive diabetes and obesity research by graduate students, postdoctoral fellows, and early stage investigators. The program seeks to stimula...
A Guide to STELLUX® Chemiluminscence ELISAs: An Infographic
Today, multiple immunoassay platforms exist, providing scientists and clinicians with the means to measure a variety of biomarkers1,2,3. However, research indicates some immunoassay platforms have limitations that can inhibit progress in the laboratory4,5,6. In an effort to provide researchers with ...
ALPCO Announces Summer 2019 Diabetes Research Travel Grant Recipient
Salem, NH, September 23, 2019
FOR IMMEDIATE RELEASE - Today ALPCO announced that the latest recipient of its Young Investigator Award: The Diabetes Research Travel Grant is Daniel M. Tremmel from the University of Wisconsin. Mr. Tremmel is a PhD student in the Cellular and Molecular Biology Progr...
Now Available: 510(k) Cleared Fecal Calprotectin ELISA
ALPCO received 510(k) clearance from the US FDA for its new fecal Calprotectin Chemiluminescence ELISA test.
The ALPCO Calprotectin Chemiluminescence ELISA’s superior clinical accuracy will enable clinical laboratories to provide the most accurate results to gastroenterologists facing the cha...
Marlena Holter Named ALPCO’s Winter 2020 Diabetes Research Travel Grant Recipient
Salem, NH, April 14, 2020
FOR IMMEDIATE RELEASE – Today ALPCO announced Marlena Holter from Cornell University, College of Veterinary Medicine as the latest recipient of its Diabetes Research Travel Grant. Ms. Holter is a DVM/PhD candidate in the Biomedical and Biological Sciences Program researc...
Ampersand Capital Partners Acquires American Laboratory Products Company
FOR IMMEDIATE RELEASE
Salem, NH – September 21, 2020: American Laboratory Products Company, Ltd. (ALPCO), a specialty in vitro diagnostics company, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support ALPCO’s wo...